You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Burrows Scott L · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$381.89K
Burrows Scott L Chief Financial Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
SYRE daily price context
Close on/before transaction
$88.5
Sep 1, 2026
First close after public filing
$88.98
Sep 4, 2026
30-day return after filing
+4.2%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,384 shares @ $87.11
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000109
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$2.39M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 2, 2026 | $1.63M |
| Spyre Therapeutics, Inc. SYRE | Exercise | Sep 1, 2026 | $108.75K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $77.63K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $17.81K |
| Spyre Therapeutics, Inc. SYRE | Sale | Sep 1, 2026 | $177.47K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Sep 1, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Sep 1, 2026 | $381.89K |